STAT

My decade leading the WHO: dirty fights and steps toward universal coverage

Dr. Margaret Chan looks back at her 10-year tenure as director-general of the World Health Organization. She steps down from that post on June 30, 2017.
Departing WHO Director-General Margaret Chan

As a young doctor working in Hong Kong’s department of maternal and child health, I learned some lessons that would last me a lifetime. Trained by the British civil service, I absorbed the importance of discipline and a methodical approach to every task. But I always ran behind schedule in my appointments with patients because I spent time trying to find the root causes of illnesses that came as much from social circumstances as from microbes. I could cure a child with a severe respiratory illness, but when that child went home to a damp and moldy house, I knew I would see her again with the same illness.

In 1994, when I became the director of Hong Kong’s department of health, I learned the lesson that it is wise to do whatever it takes to get government

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks